ダトポタマブ デルクステカン（Dato-DXd/DS-1062）の日本におけるトリプルネガティブ乳がん一次治療に係る一部変更承認申請について

Daiichi Sankyo Co. Ltd. published this content on February 12, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on February 12, 2026 at 06:53 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]